AsiaPulse News - ANTICONVULSANT DRUG, TOPAMAX REDUCES MIGRAINE FREQUENCY.
(Full text of statement. Contact details below.)
LONDON, Sept 23 PRNewswire Asia-AsiaNet — A new study presented today at the 14th Migraine Trust International Symposium shows that topiramate, marketed around the world primarily as Topamax(R), can significantly reduce both the frequency and duration of monthly migraine-headache episodes in chronic sufferers.
Related Results
Ortho-McNeil, J&J step up the fight against dispensing errors.(OrthoMcNei…
NEWS: Update
WALL STREET CHOICE J&J SHARES REFLECT SLOWING PHARMA GROWTH
Safety Alert Issued for Topiramate
New indication for antiepieptic drug
Migraine headaches are listed by the World Health Organization as one of the most disabling chronic health conditions, and are estimated to affect 15-18 percent of women and 6-9 percent of men in the United States and Western Europe. Prevalence estimates are not available for other regions of …
Want to read the whole article? You can purchase it here. It’s quick and easy.
